Xiaohua Li
Department of Psychiatry and Behavioral Neuroscience
University of Alabama at Birmingham
Birmingham
AL 35294
USA
Name/email consistency: high
- Review of pharmacological treatment in mood disorders and future directions for drug development. Li, X., Frye, M.A., Shelton, R.C. Neuropsychopharmacology (2012)
- Glycogen Synthase Kinase-3{beta} Is a Functional Modulator of Serotonin-1B Receptors. Chen, L., Zhou, W., Chen, P.C., Gaisina, I., Yang, S., Li, X. Mol. Pharmacol. (2011)
- Is glycogen synthase kinase-3 a central modulator in mood regulation? Li, X., Jope, R.S. Neuropsychopharmacology (2010)
- Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Li, X., Rosborough, K.M., Friedman, A.B., Zhu, W., Roth, K.A. Int. J. Neuropsychopharmacol. (2007)
- Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Li, X., Friedman, A.B., Zhu, W., Wang, L., Boswell, S., May, R.S., Davis, L.L., Jope, R.S. Biol. Psychiatry (2007)
- Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study. Li, X., May, R.S., Tolbert, L.C., Jackson, W.T., Flournoy, J.M., Baxter, L.R. J. Clin. Psychiatry (2005)
- In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Li, X., Zhu, W., Roh, M.S., Friedman, A.B., Rosborough, K., Jope, R.S. Neuropsychopharmacology (2004)
- Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?. Li, X., Ketter, T.A., Frye, M.A. J. Affect. Disord (2002)